Bone Loss Treatments:
Age Requirement: >= 18
Duration: 1 year(s)
Documented Diagnosis: Yes
Medical Test Required: No
Reauthorization Required: No
Duration of Reauthorization: N/A
Drug Policy Based On: Payer Specific
Diagnosis Types: 1 of Bone loss in men with non-metastatic Prostate Cancer receiving Anti-Androgen therapy;Bone loss in women with Breast Cancer receiving Aromatase Inhibitor therapy
Considered Investigational and Excluded from Coverage: all other conditions
Required Medical Information: History of vertebral fracture or low trauma or fragility fractures
Supporting Documentation Must Be Submitted: No
Inclusion Criteria: 1 of For breast cancer: must be receiving aromatase inhibitor therapy;For non-metastatic prostate cancer: must be receiving androgen deprivation therapy

Osteoporosis: Post Menopausal Women:
Age Requirement: >= 18
Duration: 1 year(s)
Medical Test Required: No
Reauthorization Required: Yes
Duration of Reauthorization: Unspecified
History of Fracture Required: Variable
BMD T-score at neck, total hip, or lumbar spine: <= -3
Self-Administration Allowed: No
Multiple fractures required: No
Documented Diagnosis: Yes